KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Staar Surgical (STAA) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to 19.52%.

  • Staar Surgical's EBITDA Margin rose 131000.0% to 19.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 41.97%, marking a year-over-year decrease of 495100.0%. This contributed to the annual value of 4.02% for FY2024, which is 127300.0% down from last year.
  • According to the latest figures from Q3 2025, Staar Surgical's EBITDA Margin is 19.52%, which was up 131000.0% from 67.61% recorded in Q2 2025.
  • Staar Surgical's 5-year EBITDA Margin high stood at 20.99% for Q3 2022, and its period low was 134.78% during Q1 2025.
  • Its 5-year average for EBITDA Margin is 3.92%, with a median of 10.67% in 2023.
  • Per our database at Business Quant, Staar Surgical's EBITDA Margin skyrocketed by 200700bps in 2021 and then plummeted by -1318300bps in 2025.
  • Staar Surgical's EBITDA Margin (Quarter) stood at 12.51% in 2021, then crashed by -88bps to 1.51% in 2022, then surged by 806bps to 13.64% in 2023, then plummeted by -518bps to 57.02% in 2024, then skyrocketed by 134bps to 19.52% in 2025.
  • Its EBITDA Margin was 19.52% in Q3 2025, compared to 67.61% in Q2 2025 and 134.78% in Q1 2025.